Janney Montgomery Scott
CPRX

Janney Montgomery Scott’s Catalyst Pharmaceutical CPRX Stock Holding History

Janney Montgomery Scott’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$821K Sell
26,136
-936
-3% -$27.6K ﹤0.01% 2039
2026
Q1 		$670K Sell
27,072
-45,385
-63% -$1.08M ﹤0.01% 1882
2025
Q4 		$1.69M Buy
72,457
+48,585
+204% +$1.08M ﹤0.01% 1436
2025
Q3 		$470K Buy
23,872
+3,542
+17% +$72.8K ﹤0.01% 2184
2025
Q2 		$441K Buy
20,330
+76
+0.4% +$1.79K ﹤0.01% 2089
2025
Q1 		$491K Sell
20,254
-3,075
-13% -$69.2K ﹤0.01% 1994
2024
Q4 		$487K Buy
23,329
+407
+2% +$8.74K ﹤0.01% 2016
2024
Q3 		$456K Hold
22,922
– – ﹤0.01% 2034
2024
Q2 		$355K Buy
22,922
+75
+0.3% +$1.17K ﹤0.01% 2117
2024
Q1 		$364K Buy
22,847
+37
+0.2% +$558 ﹤0.01% 2208
2023
Q4 		$383K Sell
22,810
-850
-4% -$11.6K ﹤0.01% 2082
2023
Q3 		$277K Sell
23,660
-462
-2% -$6.18K ﹤0.01% 2180
2023
Q2 		$324K Sell
24,122
-23,621
-49% -$340K ﹤0.01% 2177
2023
Q1 		$792K Buy
47,743
+4,939
+12% +$81.5K ﹤0.01% 1440
2022
Q4 		$796K Buy
42,804
+25,032
+141% +$385K ﹤0.01% 1488
2022
Q3 		$228K Hold
17,772
– – ﹤0.01% 2195
2022
Q2 		$122K Buy
17,772
+1,000
+6% +$7.33K ﹤0.01% 2218
2022
Q1 		$139K Buy
+16,772
New +$119K ﹤0.01% 2154
2014
Q4 		– Sell
-10,000
Closed -$33.2K – 2332
2014
Q3 		$33.2K Hold
10,000
– – ﹤0.01% 2249
2014
Q2 		$25.3K Hold
10,000
– – ﹤0.01% 2187
2014
Q1 		$22.6K Hold
10,000
– – ﹤0.01% 2015
2013
Q4 		$19.5K Buy
+10,000
New +$20.2K ﹤0.01% 1985

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janney Montgomery Scott's CPRX Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Catalyst Pharmaceutical (CPRX) stake by 3.5% in Q2 2026, selling an estimated $27.6K and leaving 26,136 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Janney Montgomery Scott first reported a position in CPRX in Q4 2013 and has held it in 22 quarters since. The position peaked at $1.69M in Q4 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Janney Montgomery Scott held 26,136 shares of Catalyst Pharmaceutical worth $821K as of Q2 2026.
  • Janney Montgomery Scott sold 936 Catalyst Pharmaceutical shares in Q2 2026, an estimated $27.6K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2039 holding.
  • Janney Montgomery Scott first reported a position in Catalyst Pharmaceutical in Q4 2013 and has held it in 22 quarters since.
  • Janney Montgomery Scott's Catalyst Pharmaceutical position peaked at $1.69M in Q4 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.